SCHEMBL4025679

SCHEMBL4025679

O=C1c2ccccc2S(=O)(=O)N1CCCCCN1CCC(c2nc(-c3ccncc3)c(-c3ccc(Cl)c(Cl)c3)[nH]2)CC1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 14/20 0.53
DRD2 P14416 13/20 0.53
HTR2A P28223 13/20 0.53
HTR7 P34969 13/20 0.53
HTR6 P50406 13/20 0.53
ABCB11 O95342 1/20 0.46
ALDH1A1 P00352 1/20 0.46
CYP1A2 P05177 1/20 0.46
ADRA2A P08913 1/20 0.46
CYP2D6 P10635 1/20 0.46
ADRA2B P18089 1/20 0.46
ADRA2C P18825 1/20 0.46
DRD4 P21917 1/20 0.46
ADRA1D P25100 1/20 0.46
CYP2C19 P33261 1/20 0.46
ADRA1A P35348 1/20 0.46
ADRA1B P35368 1/20 0.46
DRD3 P35462 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4025276 1.00 HTR1A (0.53) HTR1ADRD2HTR2AHTR7HTR6
SCHEMBL4027898 0.99 HTR1A (0.51) HTR1ADRD2HTR2AHTR7HTR6
SCHEMBL4029363 0.98 HTR1A (0.49) HTR1ADRD2HTR2AHTR7HTR6
SCHEMBL4025250 0.87 BRAF (0.43) HTR1ADRD2DRD4ADRA1DADRA1A
SCHEMBL4024657 0.87 BRAF (0.43) HTR1ADRD2DRD4ADRA1DADRA1A
SCHEMBL4031401 0.86 BRAF (0.43) HTR1ADRD2DRD4ADRA1DADRA1A
SCHEMBL4025420 0.84 BRAF (0.43) HTR1AADRA1DADRA1AADRA1B
SCHEMBL4025765 0.84 BRAF (0.42) HTR1ADRD2HTR7DRD3
SCHEMBL7744430 0.81 BRAF (0.43)
SCHEMBL4025941 0.79 DRD2 (0.47) DRD2CYP1A2CYP2D6DRD4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0854870-B1 SUBSTITUTED IMIDAZOLES HAVING ANTI-CANCER AND CYTOKINE INHIBITORY ACTIVITY MERCK & CO INC (US) 2009-06-10 EP claimed
EP-0854870-B1 SUBSTITUTED IMIDAZOLES HAVING ANTI-CANCER AND CYTOKINE INHIBITORY ACTIVITY MERCK & CO INC (US) 2009-06-10 EP disclosed
EP-0854870-B1 SUBSTITUTED IMIDAZOLES HAVING ANTI-CANCER AND CYTOKINE INHIBITORY ACTIVITY MERCK & CO INC (US) 2009-06-10 EP disclosed
US-6083949-A FOR TREATING CANCER IN WHICH RAF KINASE IS IMPLICATED, AS WELL AS COMPOUNDS WHICH INHIBIT, SUPPRESS OR ANTAGONIZE THE PRODUCTION OR ACTIVITY OF CYTOKINES SUCH AS INTERLEUKINS AND TUMOR NECROSIS FACTOR MERCK & CO., INC. (US) 2000-07-04 US disclosed
US-6063785-A ISOMERS OF DRUGS FOR RACEMIC MIXTURES ORTHO-MCNEIL PHARMACEUTICAL INC. (US) 2000-05-16 US disclosed